You have 9 free searches left this month | for more free features.

cholangiocarcinoma of the gallbladder

Showing 1 - 25 of 861

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Extrahepatic Bile Duct Adenocarcinoma, Biliary Type, Gallbladder Adenocarcinoma, Biliary Type, Metastatic Pancreatic

Active, not recruiting
  • Extrahepatic Bile Duct Adenocarcinoma, Biliary Type
  • +27 more
  • Los Angeles, California
  • +2 more
Aug 5, 2022

Potentially Resectable Locally Advanced Intrahepatic Cholangiocarcinoma and Gallbladder Cancer Trial in Tianjin

Recruiting
  • Potentially Resectable Locally Advanced Intrahepatic Cholangiocarcinoma and Gallbladder Cancer
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute & Hospital
Nov 16, 2022

Carcinoma, Intrahepatic Cholangiocarcinoma, Gallbladder Cancer Trial (HAIC, Surufatinib, Tislelizumab)

Not yet recruiting
  • Carcinoma
  • +7 more
  • (no location specified)
Nov 12, 2023

Esophageal Cancer, Head and Neck Squamous Cell Carcinoma, Advanced Head and Neck Squamous Cell Carcinoma Trial (LSTA1,

Not yet recruiting
  • Esophageal Cancer
  • +9 more
  • (no location specified)
Feb 2, 2023

Multi-Platform Profiling of Resected Biliary Tract Cancer

Recruiting
  • Biliary Tract Cancer
  • +7 more
  • Multi-Platform Profiling with Organoid Drug Sensitivity Screening and ctDNA Monitoring
  • Chicago, Illinois
  • +1 more
Jan 23, 2023

Cholangiocarcinoma, Stage III Gallbladder Cancer AJCC v7, Stage IIIA Gallbladder Cancer AJCC v7 Trial in Scottsdale, Rochester

Active, not recruiting
  • Cholangiocarcinoma
  • +6 more
  • Laboratory Biomarker Analysis
  • Trifluridine/Tipiracil Hydrochloride Combination Agent TAS-102
  • Scottsdale, Arizona
  • +1 more
Jan 4, 2023

Biliary Tract Diseases, Gallbladder Cancer, Extrahepatic Bile Duct Cancer Trial (no interventions)

Not yet recruiting
  • Biliary Tract Diseases
  • +5 more
  • no interventions
  • (no location specified)
Jun 1, 2023

Patients With Cholangiocarcinoma and Gallbladder Cancer

Recruiting
  • Biliary Tract Cancer
  • +2 more
    • Herlev, Copenhagen, Denmark
      Herlev & Gentofte Hospital
    Dec 21, 2021

    Cholangiocarcinoma, Liver and Intrahepatic Bile Duct Carcinoma, Stage III Gallbladder Cancer AJCC v7 Trial in Houston

    Completed
    • Cholangiocarcinoma
    • +11 more
    • Laboratory Biomarker Analysis
    • Ramucirumab
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 7, 2022

    Esophageal Cancer, Small Bowel Cancer, Gastroesophageal-junction Cancer Trial in Sacramento (Ablative local therapy)

    Recruiting
    • Esophageal Cancer
    • +10 more
    • Ablative local therapy
    • Sacramento, California
      University of California, Davis
    Oct 27, 2023

    Cholangiocarcinoma, Hilar, Biliary Stricture, Hilar Cholangiocarcinoma Trial in Hangzhou (Endoscopic nasobiliary duct cutting,

    Recruiting
    • Cholangiocarcinoma, Hilar
    • +6 more
    • Endoscopic nasobiliary duct cutting
    • Bilateral plastic stent
    • Hangzhou, Zhejiang, China
      Hangzhou First People's Hospital
    Oct 24, 2023

    Biliary Tract Cancer, Cholangiocarcinoma, Gallbladder Cancer Trial in Seongnam-si (nab-paclitaxel plus gemcitabine-cisplatin)

    Recruiting
    • Biliary Tract Cancer
    • +2 more
    • nab-paclitaxel plus gemcitabine-cisplatin
    • Seongnam-si, Gyeonggi-do, Korea, Republic of
      CHA Bundang Medical Center
    Oct 27, 2022

    Biliary Tract Tumors, Gallbladder Cancer, Cholangiocarcinoma Trial in Seoul (Durvalumab + Gem/Cis, Gem/Cis)

    Active, not recruiting
    • Biliary Tract Neoplasms
    • +2 more
    • Seoul, Korea, Republic of
      Asan Medical Center
    Jan 30, 2023

    Pancreatic Cancer, Cholangiocarcinoma, Gallbladder Cancer Trial in Seoul (cell free DNA in blood and urine,

    Recruiting
    • Pancreatic Cancer
    • +2 more
    • cell free DNA in blood and urine, metabolite/microbiome in urine and stool
    • Seoul, Korea, Republic of
    • +1 more
    Nov 2, 2022

    Therapeutic Assistance and Decision-making Algorithms in

    Not yet recruiting
    • Hepatocellular Carcinoma
    • +5 more
    • ADBoard
    • Berlin, Germany
      Surgical Clinic, Campus Virchow-Klinikum / Campus Charité Mitte,
    Jan 12, 2023

    Cholangiocarcinoma, Gall Bladder Carcinoma, Cholangiocarcinoma Non-resectable Trial in Hannover (Durvalumab, Gemcitabine,

    Active, not recruiting
    • Cholangiocarcinoma
    • +3 more
    • Durvalumab
    • +3 more
    • Hannover, Germany
      Medizinische Hochschule Hannover, Klinik für Gastroenterologie,
    Oct 14, 2021

    Distal Bile Duct Adenocarcinoma, Gallbladder Carcinoma, Intrahepatic Cholangiocarcinoma Trial in Duarte (Cisplatin, Gemcitabine,

    Suspended
    • Distal Bile Duct Adenocarcinoma
    • +7 more
    • Duarte, California
      City of Hope Medical Center
    Dec 8, 2022

    Advanced Bile Duct Carcinoma, Advanced Gallbladder Carcinoma, Refractory Bile Duct Carcinoma Trial in Rochester (Irinotecan,

    Active, not recruiting
    • Advanced Bile Duct Carcinoma
    • +17 more
    • Rochester, Minnesota
      Mayo Clinic
    Jan 5, 2023

    Stage III Intrahepatic Cholangiocarcinoma AJCC v7, Stage IIIA Gallbladder Cancer AJCC v7, Stage IIIB Gallbladder Cancer AJCC v7

    Completed
    • Stage III Intrahepatic Cholangiocarcinoma AJCC v7
    • +8 more
    • Scottsdale, Arizona
    • +2 more
    Jan 5, 2022

    Capecitabine Versus S-1 as Adjuvant Therapy in Biliary Tract

    Recruiting
    • Biliary Tract Neoplasms
    • +3 more
    • Shanghai, China
      Huashan hospital
    Aug 16, 2022

    Recurrent Biliary Tract Carcinoma, Recurrent Distal Bile Duct Adenocarcinoma, Recurrent Gallbladder Carcinoma Trial

    Not yet recruiting
    • Recurrent Biliary Tract Carcinoma
    • +13 more
    • (no location specified)
    Nov 8, 2022

    Biliary Tract Cancer, Cholangiocarcinoma, Gall Bladder Cancer Trial (CTX-009, Paclitaxel)

    Not yet recruiting
    • Biliary Tract Cancer
    • +3 more
    • (no location specified)
    Aug 16, 2022

    Hepatobiliary Tumors Tissue Samples Acquisition

    Recruiting
    • Hepatocellular Carcinoma
    • +7 more
    • Gene expression analysis
    • +10 more
    • Beijing, Beijing, China
      Chinese Academy of Medical Sciences & Peking Union Medical Colle
    Jun 8, 2022

    Head and Neck Squamous Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma, Non-Resectable Cholangiocarcinoma Trial in Los

    Active, not recruiting
    • Head and Neck Squamous Cell Carcinoma
    • +15 more
    • Los Angeles, California
    • +1 more
    Aug 5, 2022

    Biliary Tract Cancer, Cholangiocarcinoma, Gallbladder Cancer Trial in Worldwide (M7824)

    Completed
    • Biliary Tract Cancer
    • +2 more
    • Scottsdale, Arizona
    • +32 more
    Oct 21, 2022